We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Scansource
SCSC
$1.14B
| $70K | ﹤0.01% |
1,999
| – | – |
|
|
DBTX
1752
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $70K | ﹤0.01% |
15,000
| – | – |
|
1753
Coherus Oncology
CHRS
$188M
| $68K | ﹤0.01% |
4,231
-6,900
| -62% | -$121K |
|
1754
Champion Homes
SKY
$4.61B
| $68K | ﹤0.01% |
856
+255
| +42% | +$18.4K |
|
1755
Annaly Capital Management
NLY
$16B
| $67K | ﹤0.01% |
2,153
+1
| +0% | +$34 |
|
|
CNSL
1756
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $67K | ﹤0.01% |
8,910
-1,117
| -11% | -$9.2K |
|
1757
Applied Industrial Technologies
AIT
$11.6B
| $66K | ﹤0.01% |
646
-817
| -56% | -$81.8K |
|
1758
First Guaranty Bancshares
FGBI
$140M
| $66K | ﹤0.01% |
3,259
-15
| -0.5% | -$300 |
|
1759
Nuvation Bio
NUVB
$2.03B
| $65K | ﹤0.01% |
7,594
-10,842
| -59% | -$99.7K |
|
1760
Opko Health
OPK
$1.2B
| $65K | ﹤0.01% |
13,427
-17,028
| -56% | -$68.9K |
|
1761
World Acceptance Corp
WRLD
$865M
| $65K | ﹤0.01% |
265
+78
| +42% | +$17K |
|
1762
Fulgent Genetics
FLGT
$595M
| $64K | ﹤0.01% |
638
-808
| -56% | -$71K |
|
1763
Host Hotels & Resorts
HST
$14.9B
| $64K | ﹤0.01% |
+3,661
| New | +$61.8K |
|
|
NEUE
1764
DELISTED
NeueHealth
NEUE
| $64K | ﹤0.01% |
+232
| New | +$107K |
|
|
MODV
1765
DELISTED
ModivCare
MODV
| $63K | ﹤0.01% |
422
-535
| -56% | -$82.8K |
|
1766
NIO
NIO
$8.97B
| $63K | ﹤0.01% |
1,988
-2,876
| -59% | -$106K |
|
1767
Regional Management Corp
RM
$296M
| $63K | ﹤0.01% |
1,103
| – | – |
|
|
DNB
1768
DELISTED
Dun & Bradstreet
DNB
| $61K | ﹤0.01% |
2,975
| – | – |
|
1769
American Airlines Group
AAL
$8.41B
| $59K | ﹤0.01% |
3,259
-3,064
| -48% | -$58.8K |
|
1770
Cue Biopharma
CUE
$248M
| $59K | ﹤0.01% |
174
+46
| +36% | +$17.8K |
|
|
JBTM
1771
JBT Marel
JBTM
$5.78B
| $59K | ﹤0.01% |
383
-167
| -30% | -$26.1K |
|
1772
Group 1 Automotive
GPI
$3.13B
| $58K | ﹤0.01% |
295
-376
| -56% | -$73.1K |
|
1773
HEICO Corp Class A
HEI.A
$31.1B
| $58K | ﹤0.01% |
449
-49
| -10% | -$6.23K |
|
1774
Mueller Industries
MLI
$13.4B
| $58K | ﹤0.01% |
3,928
-4,976
| -56% | -$67.3K |
|
1775
Knowles
KN
$3B
| $57K | ﹤0.01% |
2,428
| – | – |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.